María Romina Girotti

5.0k total citations · 2 hit papers
44 papers, 3.0k citations indexed

About

María Romina Girotti is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, María Romina Girotti has authored 44 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 24 papers in Oncology and 9 papers in Immunology. Recurrent topics in María Romina Girotti's work include Melanoma and MAPK Pathways (12 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Cancer Genomics and Diagnostics (8 papers). María Romina Girotti is often cited by papers focused on Melanoma and MAPK Pathways (12 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Cancer Genomics and Diagnostics (8 papers). María Romina Girotti collaborates with scholars based in Argentina, United Kingdom and United States. María Romina Girotti's co-authors include Richard Marais, Erik Sahai, Amaya Virós, James Larkin, Caetano Reis e Sousa, Sophie E. Acton, Probir Chakravarty, Annemarthe G. van der Veen, Jan P. Böttcher and Neil C. Rogers and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

María Romina Girotti

43 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity

2015 825 citations María Romina Girotti, Richard Marais et al. profile →
Intravital Imaging Reveals How BRAF Inhibition Generates Drug-Tolerant Microenvironments with High Integrin β1/FAK Signaling

2015 420 citations María Romina Girotti, Amaya Virós et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
María Romina Girotti Argentina	21	1.6k	1.4k	827	628	302	44	3.0k
Parthasarathy Seshacharyulu United States	29	1.7k 1.1×	1.1k 0.8×	435 0.5×	595 0.9×	421 1.4×	53	2.9k
Lori Hazlehurst United States	35	2.5k 1.6×	1.9k 1.4×	575 0.7×	557 0.9×	223 0.7×	91	4.6k
Álvaro J. Obaya Spain	26	2.1k 1.4×	1.1k 0.8×	328 0.4×	723 1.2×	160 0.5×	49	3.3k
Eugene Tulchinsky United Kingdom	31	2.8k 1.8×	1.3k 0.9×	604 0.7×	1.1k 1.8×	403 1.3×	49	3.7k
Cristina Nadal Spain	17	2.2k 1.4×	2.3k 1.6×	475 0.6×	1.3k 2.0×	726 2.4×	42	4.3k
Graham F. Barnard United States	25	1.6k 1.0×	1.5k 1.0×	405 0.5×	756 1.2×	302 1.0×	63	3.0k
Arnulfo Mendoza United States	26	1.5k 0.9×	965 0.7×	357 0.4×	636 1.0×	789 2.6×	51	2.8k
Lídia Robert United States	20	2.0k 1.3×	2.0k 1.4×	1.3k 1.6×	544 0.9×	529 1.8×	26	3.7k
Rodney B. Luwor Australia	32	2.0k 1.3×	1.5k 1.0×	485 0.6×	867 1.4×	428 1.4×	95	3.7k
Marya F. McCarty United States	29	2.0k 1.3×	1.1k 0.8×	436 0.5×	869 1.4×	285 0.9×	37	3.0k

Countries citing papers authored by María Romina Girotti

Since Specialization

Citations

This map shows the geographic impact of María Romina Girotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Romina Girotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Romina Girotti more than expected).

Fields of papers citing papers by María Romina Girotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Romina Girotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Romina Girotti. The network helps show where María Romina Girotti may publish in the future.

Co-authorship network of co-authors of María Romina Girotti

This figure shows the co-authorship network connecting the top 25 collaborators of María Romina Girotti. A scholar is included among the top collaborators of María Romina Girotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Romina Girotti. María Romina Girotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Girotti, María Romina, et al.. (2023). Unraveling tumor specific neoantigen immunogenicity prediction: a comprehensive analysis. Frontiers in Immunology. 14. 1094236–1094236. 7 indexed citations

Girotti, María Romina, et al.. (2023). Novel evaluation approach for molecular signature-based deconvolution methods. Journal of Biomedical Informatics. 142. 104387–104387. 3 indexed citations

Fresno, Cristóbal, et al.. (2022). Liquid biopsy for KRAS, NRAS and BRAF mutation testing in advanced colorectal cancer patients: the Argentinean experience. Future Oncology. 18(29). 3277–3287. 5 indexed citations

Enrico, Diego, et al.. (2022). Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report. JTO Clinical and Research Reports. 4(2). 100456–100456. 9 indexed citations

Morosi, Luciano Gastón, Alejandro J. Cagnoni, Diego O. Croci, et al.. (2021). Control of intestinal inflammation by glycosylation-dependent lectin-driven immunoregulatory circuits. Science Advances. 7(25). 16 indexed citations

Rabinovich, Gabriel A., et al.. (2021). Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma. Cancers. 13(5). 1018–1018. 27 indexed citations

Llera, Andrea S., et al.. (2020). Pan-Cancer Molecular Patterns and Biological Implications Associated with a Tumor-Specific Molecular Signature. Cells. 10(1). 45–45. 5 indexed citations

Girotti, María Romina, Mariana Salatino, Tomás Dalotto‐Moreno, & Gabriel A. Rabinovich. (2019). Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression. The Journal of Experimental Medicine. 217(2). 131 indexed citations

Khandelwal, Garima, María Romina Girotti, Christopher Smowton, et al.. (2017). Next-Generation Sequencing Analysis and Algorithms for PDX and CDX Models. Molecular Cancer Research. 15(8). 1012–1016. 33 indexed citations

10.

Valpione, Sara, Gabriela Gremel, Piyushkumar A. Mundra, et al.. (2017). Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients. European Journal of Cancer. 88. 1–9. 116 indexed citations

11.

Spender, Lindsay C., Gail Ferguson, Sijia Liu, et al.. (2016). Mutational activation of BRAF confers sensitivity to transforming growth factor beta inhibitors in human cancer cells. Oncotarget. 7(50). 81995–82012. 18 indexed citations

12.

Girotti, María Romina, Gabriela Gremel, Rebecca Lee, et al.. (2016). Application of sequencing, liquid biopsies and patient-derived xenografts for personalized medicine in melanoma. European Journal of Cancer. 61. S193–S193. 1 indexed citations

13.

Baenke, Franziska, Barbara Chaneton, Matthew Smith, et al.. (2015). Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells. Molecular Oncology. 10(1). 73–84. 131 indexed citations

14.

Virós, Amaya, Berta Sanchez‐Laorden, Malin Pedersen, et al.. (2014). Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53. Nature. 511(7510). 478–482. 164 indexed citations

15.

Girotti, María Romina, Grazia Saturno, Paul Lorigan, & Richard Marais. (2014). No longer an untreatable disease: How targeted and immunotherapies have changed the management of melanoma patients. Molecular Oncology. 8(6). 1140–1158. 34 indexed citations

16.

Girotti, María Romina, Malin Pedersen, Berta Sanchez‐Laorden, et al.. (2013). Abstract 3404: Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma.. Cancer Research. 73(8_Supplement). 3404–3404. 1 indexed citations

17.

Girotti, María Romina, Malin Pedersen, Berta Sanchez‐Laorden, et al.. (2012). Inhibiting EGF Receptor or SRC Family Kinase Signaling Overcomes BRAF Inhibitor Resistance in Melanoma. Cancer Discovery. 3(2). 158–167. 272 indexed citations

18.

Girotti, María Romina, Marisol Fernández, Juan Antonio López, et al.. (2011). SPARC Promotes Cathepsin B-Mediated Melanoma Invasiveness through a Collagen I/α2β1 Integrin Axis. Journal of Investigative Dermatology. 131(12). 2438–2447. 56 indexed citations

19.

Llera, Andrea S., María Romina Girotti, Lorena Benedetti, & Osvaldo L. Podhajcer. (2009). Matricellular proteins and inflammatory cells: A task force to promote or defeat cancer?. Cytokine & Growth Factor Reviews. 21(1). 67–76. 14 indexed citations

20.

Sosa, María Soledad, María Romina Girotti, Edgardo Salvatierra, et al.. (2007). Proteomic analysis identified N‐cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells. PROTEOMICS. 7(22). 4123–4134. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact